HC Wainwright Cuts Tempus AI (NASDAQ:TEM) Price Target to $89.00

Tempus AI (NASDAQ:TEM) had its price objective trimmed by HC Wainwright from $98.00 to $89.00 in a research report report published on Friday,Benzinga reports. They currently have a buy rating on the stock.

Other research analysts have also recently issued reports about the company. Weiss Ratings reissued a “sell (d-)” rating on shares of Tempus AI in a report on Wednesday, October 8th. Cowen lowered shares of Tempus AI from a “buy” rating to a “hold” rating in a report on Tuesday, October 21st. Piper Sandler lifted their price target on shares of Tempus AI from $70.00 to $105.00 and gave the company a “neutral” rating in a report on Wednesday, October 22nd. Canaccord Genuity Group decreased their price objective on shares of Tempus AI from $110.00 to $95.00 and set a “buy” rating on the stock in a research note on Wednesday. Finally, TD Cowen lowered shares of Tempus AI from a “buy” rating to a “hold” rating and set a $88.00 price objective for the company. in a report on Tuesday, October 21st. Seven investment analysts have rated the stock with a Buy rating, eight have issued a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat.com, the company presently has an average rating of “Hold” and a consensus price target of $79.85.

Tempus AI Stock Down 0.7%

Shares of TEM opened at $71.56 on Friday. The company has a quick ratio of 3.12, a current ratio of 3.28 and a debt-to-equity ratio of 2.45. The company has a 50-day moving average price of $85.91 and a two-hundred day moving average price of $71.17. The stock has a market cap of $12.43 billion, a price-to-earnings ratio of -60.13 and a beta of 4.86. Tempus AI has a 12 month low of $31.36 and a 12 month high of $104.32.

Tempus AI (NASDAQ:TEM) last issued its earnings results on Tuesday, November 4th. The company reported ($0.11) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.16) by $0.05. The business had revenue of $334.21 million during the quarter, compared to analysts’ expectations of $328.89 million. Tempus AI had a negative return on equity of 73.21% and a negative net margin of 18.45%.Tempus AI’s quarterly revenue was up 84.7% compared to the same quarter last year. During the same period in the prior year, the firm posted ($0.46) EPS. Tempus AI has set its FY 2025 guidance at EPS. Equities analysts predict that Tempus AI will post -6.15 EPS for the current fiscal year.

Insider Activity

In other news, COO Ryan Fukushima sold 5,000 shares of the company’s stock in a transaction that occurred on Monday, November 3rd. The shares were sold at an average price of $89.03, for a total transaction of $445,150.00. Following the transaction, the chief operating officer directly owned 125,000 shares in the company, valued at approximately $11,128,750. This represents a 3.85% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, CAO Ryan M. Bartolucci sold 1,904 shares of the stock in a transaction that occurred on Tuesday, August 19th. The shares were sold at an average price of $74.65, for a total transaction of $142,133.60. Following the sale, the chief accounting officer directly owned 45,895 shares in the company, valued at $3,426,061.75. This trade represents a 3.98% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Over the last quarter, insiders have sold 1,105,282 shares of company stock worth $87,726,381. 26.27% of the stock is currently owned by insiders.

Institutional Inflows and Outflows

Several large investors have recently bought and sold shares of TEM. GSA Capital Partners LLP bought a new position in Tempus AI in the 3rd quarter valued at $604,000. Vanguard Group Inc. lifted its stake in shares of Tempus AI by 22.1% during the third quarter. Vanguard Group Inc. now owns 9,441,607 shares of the company’s stock valued at $762,032,000 after acquiring an additional 1,706,837 shares during the period. State of New Jersey Common Pension Fund D boosted its holdings in Tempus AI by 4.2% in the third quarter. State of New Jersey Common Pension Fund D now owns 33,111 shares of the company’s stock valued at $2,672,000 after acquiring an additional 1,323 shares during the last quarter. PNC Financial Services Group Inc. increased its position in Tempus AI by 16.2% in the third quarter. PNC Financial Services Group Inc. now owns 5,815 shares of the company’s stock worth $469,000 after purchasing an additional 812 shares during the period. Finally, Ameritas Advisory Services LLC bought a new stake in Tempus AI during the 3rd quarter worth about $843,000. Institutional investors and hedge funds own 24.22% of the company’s stock.

Tempus AI Company Profile

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.